[Source: Biospace.com] – Surgeons from Arizona Heart Institute performed the first procedure in the U.S. Anaconda Phase II Study using the Vascutek Anaconda Stent Graft System, an investigational, minimally invasive treatment for abdominal aortic aneurysm (AAA).
Leading the study efforts in the U.S. is Julio Rodriguez-Lopez, M.D., Vascular Surgeon, Arizona Heart Institute and Arizona Heart Hospital, and National Principal Investigator. “The Anaconda Stent Graft System has the potential to treat patients with infrarenal AAAs,” said Dr. Rodriguez. “In commercial use outside the U.S. Phase II study, this stent graft has been shown to be flexible and repositionable. These are important features when treating patients with infrarenal AAAs,” continued Rodriguez.
For more information click here